Treatment of gastrointestinal disease with ppar modulators

Methods and compositions are provided for treating a host having a gastrointestinal (GI) disease by administering to the host a composition containing a pharmaceutically effective amount of a modulator of a Peroxisome Proliferator Activated Receptor (PPAR), particularly a modulator of PPAR gamma . Screening methods are also provided for identifying PPAR modulators which utilize cells derived from gastrointestinal tissue which express PPARs


Year:
1998
Note:
Applicant(s): Ligand Pharm Inc [Us], Pasteur Institut [Fr], Lefebvre Anne-Marie, Auwerx Johan, Briggs Michael R
Other identifiers:
EPO Family ID: 21916159
Laboratories:




 Record created 2009-04-21, last modified 2018-03-17


Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)